Exploiting the transcriptional specificity of the alpha-methylacyl-CoA racemase <i>AMACR</i> promoter for the molecular imaging of prostate cancer.

Exploiting the transcriptional specificity of the alpha-methylacyl-CoA racemase AMACR promoter for the molecular imaging of prostate cancer.

Shapovalova, Mariya; Davydova, Julia; Henzler, Christine; Daniel, Mark; Dehm, Scott M; Warlick, Christopher A; LeBeau, Aaron M.

Afiliação

Shapovalova M; Department of Pharmacology, University of Minnesota, Minneapolis 55455, MN, USA.
Davydova J; Department of Surgery, University of Minnesota, Minneapolis 55455, MN, USA.
Henzler C; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis 55455, MN, USA.
Daniel M; Department of Microbiology and Immunology, University of Minnesota, Minneapolis 55455, MN, USA.
Dehm SM; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis 55455, MN, USA.
Warlick CA; Department of Urology, University of Minnesota, Minneapolis 55455, MN, USA.
LeBeau AM; Department of Pharmacology, University of Minnesota, Minneapolis 55455, MN, USA.

Oncotarget ; 9(94): 36693-36704, 2018 Nov 30.

Article em En | MEDLINE | ID: mdl-30613352